Navigation Links
WorldHeart Announces Possible Delisting Action by NASDAQ
Date:5/15/2008

OAKLAND, Calif., May 15 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT, TSX: WHT) World Heart Corporation (the "Company") today announced that, on May 12, 2008, it had received a NASDAQ Staff Determination Letter stating that the Company's requests for continued listing on The NASDAQ Capital Market has been denied. The NASDAQ noted that the Company did not provide a definitive plan evidencing its ability to achieve near term compliance with the continued listing requirements or sustain such compliance over an extended period of time, as required by Marketplace Rule 4310(c)(4) (the "Minimum Bid Price Rule") and Marketplace Rule 4310(c)(3), which requires the Company to have a minimum of $2.5 million in stockholders' equity or $35 million market value of listed securities or $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years. Accordingly, unless the Company requests an appeal of this determination, trading of the Company's common stock will be suspended at the opening of business on May 21, 2008, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC") which will remove the Company's securities from listing and registration on The NASDAQ Stock Market.

The Company may appeal Staff's determination to a NASDAQ Listing Qualifications Panel (the "Panel"), pursuant to the procedures set forth in the NASDAQ Marketplace Rule 4800 Series. A hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision. The request for a hearing, which may either be an oral hearing or a hearing based solely on written submissions, must be received by the Hearings Department no later than 4:00 P.M. Eastern Time on May 19, 2008. If the Company appeals, the Company must also address its failure to comply with the $1 million minimum market value requirement for its publicly held shares ("MVPHS"
'/>"/>

SOURCE World Heart Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. WorldHeart Notified of TSX Delisting Review
2. WorldHeart Appoints David Pellone Chief Financial Officer
3. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction
4. Perot Systems Announces the Launch of Xcelys(TM) 5.0 Software
5. Duane Reade Announces Proud Sponsorship of AIDS Walk New York
6. Summit VetPharm Announces Grand Prize and March Winner in its Great Vectra 3D(TM) $125,000 Giveaway
7. The Canary Foundation Announces Its Fourth Annual Early Detection Symposium
8. Sharps Compliance Corp. Announces Results for Third Quarter of Fiscal Year 2008
9. Human Pheromone Sciences Announces First Quarter Results
10. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
11. The Quantum Group Announces Web-Based Portal for Physicians

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., Wis., Dec. 4 When the ...onsin Department of Health Services needed to get ...ever before. Join Sonic Foundry, Inc. (Nasdaq: ...a webcasting and knowledge management, for a live ...artment of Health Services, will share how in-hous...
(Date:12/4/2009)... N.J., Dec. 4 Movado Gro...p; Co. Jewelers, Atlanta, Georgia, shared in a tri...n quarterfinalist Melanie Oudin for her stellar pe...ungest American quarterfinalist at the Open since ...bin/prnh/20091204/NY21184 ) ,, At a celebratory...
(Date:12/4/2009)...009 New findings by UT Southwestern researchers s...e disorders might also help slow the destruction o...gnosed with insulin-dependent (type 1) diabetes. ... diabetes, cells in the pancreas called beta cells...mmune process. , Researchers at UT Southwestern ...
(Date:12/4/2009)... Tender Corp., a leading manufacturer of over-...esigned to enhance consumers’ quality of lif...veted American Podiatric Medical Association (APMA...eam, HealthiFeet®. , ...ng manufacturer of over-the-counter topical cream ...
(Date:12/4/2009)...NEAPOLIS, Dec. 4 New data from the...ans struggled to get enough to eat at some point i...one in six Americans struggled with hunger. To wak...CEO Ken Powell, NBC,s The Biggest Loser,s Bob Harp...Escarra are teaming up to turn on the production l...
Breaking Medicine News(10 mins):Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 2Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 3Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 4
...as been revealed that every fourth Australian is h...ere doctors and risking their health. The alt...hat half the population practices it! A study ...cology department Professor Alastair MacLennan. ...
...world over have one more reason to raise a toast- ...e news on how you // can pep-up your spirits and...turer in Wine Studies at Coventry University, and ....5 + 1, where P is pressure and T is temperature-w...
...rong relationship between obesity and kidney failu...inner folk to develop kidney disease // and the ...says a US study. The link could be because obe...of medicine at the University of California, San F...
... Collector, K. Sellamuthu, has ordered distributio...hering places // such as tea stalls, hair cuttin...tlets as these are the places where large number o...he calendar would contain AIDS awareness warning w...
... that is mainly present in pain relievers. Recentl...iting the // clinicians complaining about over do...failure of the liver but about 50% of these cases ...n in them. Americans consume increased amount ...
...an be delayed to a great extent by taking walks th...ed blood flow // and leg pain, according to a re... also be improved through the exercise. As a part ...ir ability to get up from a chair unassisted. They...
Other Medicine News:Health News:Study links obesity to kidney failure 2Health News:Painkillers Lead To Liver Failure 2
(Date:12/3/2009)... 3 Allen Medical Systems... HRC ), today announced the launch of its new Alle...) business website www.AllenAmatech.com . ,...nd identity and includes an online version of the ...d design specifications for the products. "We hope...
(Date:12/3/2009)... Dec. 3 Pharmacyclics, I...focused on developing and commercializing innovati...e mediated diseases and cancer, today announced th...Tuesday, December 8, 2009 at 11:00am Eastern Time ...discuss clinical data regarding its HDAC Program (...
(Date:12/3/2009)..., Pa., Dec. 3 Radiology imaging le...ord integration capabilities at the November 2009 ...e Connect.PACS(TM) product, enabling the first r...the latest release in the company,s newly branded ...o: http://www.newscom.com/cgi-bin/prnh/20091203/...
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Sleep Apnea Expert Offers Incentives That Could Save Lives 55483 1Sleep Apnea Expert Offers Incentives That Could Save Lives 55483 2Sleep Apnea Expert Offers Incentives That Could Save Lives 55483 3EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 1Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 2Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 3
...ented at ASCO Annual Meeting -, SOUTH SAN FRANCIS...ll/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: PAR...gy, today announced safety and efficacy results,fr... of picoplatin and,liposomal doxorubicin in patien...ancer. Results demonstrated signals of clinical ac...
...cal Phase 2 data presented at American Society of ...eting, PRINCETON, N.J., June 1 Medarex, Inc.,(Na...llow-up and overall,survival (OS) results from a P...ilimumab in combination with dacarbazine (DTIC) wh...t or greater than 4 years of follow-up. This,inclu...
Other Medicine Technology:Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4
...e Albumin Cobalt Binding (ACB®) Test is a clin...d Albumin (IMA®) by measuring the cobalt bindi...First identified in the early 1990s, IMA is produc...ischemic tissue in the heart. During ischemia, the...
...r test menu includes kits that quantitatively meas...ne and lipoprotein (a). An elevated serum or plasm...trong and independent risk factor for cardiovascul...970s have associated elevated levels of Lp(a) with...
...r test menu includes kits that quantitatively meas...ne and lipoprotein (a). An elevated serum or plasm...trong and independent risk factor for cardiovascul...970s have associated elevated levels of Lp(a) with...
...verness Medical Professional Diagnostics is a lead... extensive IFA and DFA test menu that includes kit... STDs as well as miscellaneous conjugates and comp...e assortment of substrates and kit sizes to choose...
Medicine Products: